TAKE Solutions gets US patent for method for optimising clinical data standardization
TAKE Solutions Ltd., a leading domain focused technology company offering services and solutions to the global market and it provides cost-effective and comprehensive solutions for enterprises across diverse sectors including pharmaceuticals, high technology, consumer packaged goods, was awarded a patent by the United States Patent and Trademark Office (US PTO) for its “Method for Optimizing Clinical Data Standardization”. This process leverages TAKE Solutions’ clinical accelerators to reduce the time taken to standardize trial data by over 50% (when compared to standardization without the accelerators), thus reducing time to market.
At the heart of the patented Clinical Data Standardization Process are TAKE Solutions’ clinical accelerators, a set of macros that accelerate the Clinical Data Standardization process where raw data from clinical trials is standardized and transformed into CDISC SDTM format. The process includes various pre-defined steps that convert raw data into tabular datasets. This enables regulators to easily understand the data, as well as enables easy analysis of trial data.
This process is delivered by Navitas, the Life Sciences arm of TAKE Solutions. The Clinical Data Services team offers its clients the benefit of our deep domain expertise in Clinical Data solutions including – Clinical Data Standardisation, Clinical Data Management, Statistical Programming, and Data Standards.
TAKE’s global headquarters is in Chennai, India; its US headquarters is located in Princeton, New Jersey. TAKE has a proven track record as a trusted partner in delivering world-class solutions to more than 400 customers worldwide.